Disruption of estrogen receptor DNA-binding domain and related intramolecular communication restores tamoxifen sensitivity in resistant breast cancer
- 1 December 2006
- journal article
- research article
- Published by Elsevier in Cancer Cell
- Vol. 10 (6) , 487-499
- https://doi.org/10.1016/j.ccr.2006.09.015
Abstract
No abstract availableKeywords
Funding Information
- National Cancer Institute
- National Institutes of Health (NO1-CO-12400)
This publication has 63 references indexed in Scilit:
- IL-7 promotes T cell proliferation through destabilization of p27Kip1The Journal of Experimental Medicine, 2006
- Epidermal growth factor receptor/HER2/insulin-like growth factor receptor signalling and oestrogen receptor activity in clinical breast cancerEndocrine-Related Cancer, 2005
- Corepressor subnuclear organization is regulated by estrogen receptor via a mechanism that requires the DNA-binding domainMolecular and Cellular Endocrinology, 2005
- Full Activation of Estrogen Receptor α Activation Function-1 Induces Proliferation of Breast Cancer CellsJournal of Biological Chemistry, 2003
- Molecular Determinants for the Tissue Specificity of SERMsScience, 2002
- Differential sensitivity of MCF-7 and LCC2 cells, to multiple growth inhibitory agents: possible relation to high bcl-2/bax ratio?Cancer Letters, 2000
- Cofactor Dynamics and Sufficiency in Estrogen Receptor–Regulated TranscriptionCell, 2000
- Conformational Dynamics and Molecular Recognition: Backbone Dynamics of the Estrogen Receptor DNA-binding DomainJournal of Molecular Biology, 1999
- AIB1, a Steroid Receptor Coactivator Amplified in Breast and Ovarian CancerScience, 1997
- Insulin and epidermal growth factor stimulate phosphorylation of p185HER-2 in the breast carcinoma cell line, BT474Molecular and Cellular Endocrinology, 1990